Repeated Stem Cell Injections Show Safety Promise for ALS Patients
A Phase 1/2 trial tests four rounds of intrathecal MSC injections in ALS patients, targeting both safety and disease progression.
Stem cell therapies, regenerative medicine, tissue engineering, and cellular reprogramming
188 articles
A Phase 1/2 trial tests four rounds of intrathecal MSC injections in ALS patients, targeting both safety and disease progression.
New research in Nature Aging suggests tissue mechanical softness is a critical factor enabling cellular regeneration, with major implications for aging biology.
Allez plus loin dans la façon dont les exosomes sont construits, ce qu'ils transportent, et comment leur cargo moléculaire reconfigure les cellules réceptrices — avec des implications pour la régénération, le vieillissement et les thérapies émergentes.
Harvard's CellCartographer uses machine learning to identify optimal transcription factor combinations for rapid, high-efficiency cell reprogramming.
Kyoto researchers created jawbone-like organoids from human iPSCs, recapitulating mandibular development and modeling fragile bone disease.
Chinese researchers decode how chemical cocktails alone can convert adult human cells into pluripotent stem cells, bypassing gene editing.
A review of iPSC-based regenerative medicine charts the path from Parkinson's disease models to real-world cell replacement therapies.
Découvrez les exosomes — les « messages texte » microscopiques que vos cellules s'envoient pour coordonner la guérison, le vieillissement et la réparation dans tout votre organisme.
Astellas reports encouraging early-stage results for a stem cell-derived treatment targeting age-related eye disease, though data remains limited.
A comprehensive review maps how mesenchymal stem cells and their exosomes combat Alzheimer's, atherosclerosis, osteoporosis, and ovarian failure.
A novel photoactivatable drug system uses NK immune cells to eliminate aging joint cells, reducing osteoarthritis progression in mice.
Combining nanoparticles with mesenchymal stem cells could finally overcome the poor survival and differentiation that limits cartilage regeneration.